Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Dormant
Current status date:
2024-07-09
Original market date: See footnote 1
1999-02-26
Product name:
MONISTAT 1 VAGINAL OVULE
DIN:
02239601
Product Monograph/Veterinary Labelling:
Date:
2020-04-28
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
INSIGHT PHARMACEUTICALS, LLC
660 White Plains Road
Tarrytown
New York
United States
10591
Class:
Human
Dosage form(s):
Suppository
Route(s) of administration:
Vaginal
Number of active ingredient(s):
1
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
84:04.08.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
G01AF04 MICONAZOLE
Active ingredient group (AIG) number:See footnote5
0110272005
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| MICONAZOLE NITRATE | 1200 MG |